5 January 2021 - - Keith Valentine as has been appointed non-executive has been appointed chair of the board with immediate effect at UK-based orthobiologics focused regenerative medicine company Locate Bio, the company said.

Valentine joins with over 30 years' experience in the orthopaedic industry, encompassing various leadership and senior executive positions in marketing, development and operations.

Since May 2015, Valentine has served as the chief executive officer and president of SeaSpine, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, where he has successfully expanded the business and delivered significant revenue growth.

He joined SeaSpine from NuVasive, a leader in spine technology innovation, where he spent 14 years in various senior roles including president and chief operating officer from 2007 to 2015.

Prior to this, he served as vice president of Marketing at ORATEC Interventions, which was acquired by Smith and Nephew PLC in 2002, and also spent eight years in various roles with Medtronic Sofamor Danek, including as vice president of Marketing for the Rods division and Group director for the BMP Biologics program, the Interbody Sales Development Effort, and International Sales and Marketing.

The appointment follows the company's recent acquisition of multiple late stage complementary orthobiologics assets from Royal College of Surgeons in Ireland University of Medicine and Health Sciences, accelerating its route to market and broadening its orthobiologics pipeline.

The company continues to look for additional, complementary acquisitions or in-licencing opportunities that would further broaden its portfolio to provide surgeons with a choice of best-in-class technologies and products that address the current challenges of existing products and meet specific patient driven clinical needs.